Imiquimod: Basal cell carcinoma: Inferior to other treatments

Prescrire International

Volumn 15, Issue 84, 2006, Pages 130-131

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; EXCIPIENT; IMIQUIMOD; AMINOQUINOLINE DERIVATIVE; ANTINEOPLASTIC AGENT; IMMUNOLOGICAL ADJUVANT;

ANTIVIRAL ACTIVITY; ARTICLE; BASAL CELL CARCINOMA; BURNING SENSATION; CANCER RECURRENCE; CANCER RELAPSE; CLINICAL TRIAL; CREAM; DRUG DOSE REGIMEN; DRUG FEVER; DRUG INDICATION; EROSION; ERYTHEMA; EUROPE; FATALITY; FATIGUE; FLU LIKE SYNDROME; HEADACHE; HISTOPATHOLOGY; HUMAN; MYALGIA; NONHUMAN; PHOTOSENSITIZATION; PRURITUS; RISK BENEFIT ANALYSIS; SCABIES; SKIN EDEMA; SKIN EXFOLIATION; SKIN INDURATION; SKIN INFLAMMATION; SKIN PAIN; SKIN ULCER; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG APPROVAL; OINTMENT; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG APPROVAL; EUROPE; HUMANS; OINTMENTS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 33746443872     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. o. Une évaluation insuffisante" Rev Prescrire 1999; 19 (200): 733-735.
2. European Medicines Agency - CHMP "EPAR Aldara - Scientific discussion Revision 3": 24 pages; placed online on the EMEA website on 10 November 2005.
3. Beutner KR et al. "Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream" J Am Acad Dermatol 1999; 41 (6): 1002-1007.
4. Marks R et al. "Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial" J Am Acad Dermatol 2001; 44 (5): 807-813.
5. Shumack S et al. "Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma" Arch Dermatol 2002; 138: 1165-1171.
6. Sterry W et al. "Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomised studies comparing low-frequency dosing with and without occlusion" Br J Dermatol 2002; 147: 1227-1236.
7. Geisse JK et al. "Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study" J Am Acad Dermatol 2002; 47 (3): 390-398.
8. Geisse J et al. "Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies" J Am Acad Dermatol 2004; 50 (5): 722-733.
9. o". In: "Physicians' Desk Reference" 59th ed., Thomson - PDR, Montvale 2005: 1911-1916.
10. "Imiquimod". In: "Martindale The complete drug reference" 34th ed., The Pharmaceutical Press, London 2005: 638.